NBI-77860
NBI-77860-1401
Phase 1 small_molecule terminated
Quick answer
NBI-77860 for Congenital Adrenal Hyperplasia is a Phase 1 program (small_molecule) at NEUROCRINE BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NEUROCRINE BIOSCIENCES INC
- Indication
- Congenital Adrenal Hyperplasia
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated